beta-lactams has been researched along with mk-7655 in 4 studies
| Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (mk-7655) | Trials (mk-7655) | Recent Studies (post-2010) (mk-7655) |
|---|---|---|---|---|---|
| 7,579 | 179 | 3,395 | 140 | 9 | 136 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huffman, MA; Mangion, IK; Rivera, N; Ruck, RT; Shevlin, M | 1 |
| Ammerman, NC; Kaushik, A; Kreiswirth, BN; Lamichhane, G; Lee, J; Martins, O; Nuermberger, EL; Parrish, NM | 1 |
| Ammerman, NC; Kaushik, A; Nuermberger, EL; Parrish, NM | 1 |
| Bassetti, M; Battaglini, D; Giacobbe, DR; Pelosi, P; Vena, A | 1 |
1 review(s) available for beta-lactams and mk-7655
| Article | Year |
|---|---|
The role of new antimicrobials for Gram-negative infections in daily clinical practice.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; beta-Lactams; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Polymyxins; Sisomicin; Tazobactam; Tetracyclines | 2020 |
3 other study(ies) available for beta-lactams and mk-7655
| Article | Year |
|---|---|
A concise synthesis of a β-lactamase inhibitor.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactams; Humans; Iridium; Molecular Structure; Urea | 2011 |
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactams; Boronic Acids; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2019 |
New β-Lactamase Inhibitors Nacubactam and Zidebactam Improve the
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactams; Cefepime; Cyclooctanes; Microbial Sensitivity Tests; Mycobacterium abscessus; Piperidines | 2019 |